Epic Interoperability Antitrust Risk

Diving deeper into

Epic

Company Report
A federal judge allowed Particle Health's Sherman Act Section 2 antitrust claims to proceed (September 2025), finding Epic's alleged conduct "sufficiently anticompetitive."
Analyzed 5 sources

The key issue is not just one lawsuit, it is that Epic’s control over the pipes that move patient data can look like market power when it is used to decide which outside apps get reliable access. Particle sits in the interoperability layer, helping digital health companies pull records from legacy networks through a cleaner API, so a judge letting monopolization claims move forward means Epic’s network governance is now being tested as competitive conduct, not just technical policy.

  • Epic’s position is unusually strong. It serves 3,620 U.S. hospitals and health systems, about 42.3% of the acute care hospital market as of August 2025, and its Care Everywhere exchange is a built in route for Epic customers to share records with each other. That scale makes interoperability rules economically important for any startup trying to sit between providers, payers, and patients.
  • Particle is part of a broader group of healthcare API companies that package messy legacy record networks into a simpler developer product for digital health providers. In practice, these companies win by making one connection work across many institutions, so restrictions on one major network operator can directly hit product reliability, onboarding speed, and customer trust.
  • The legal pressure is broadening beyond one federal case. In December 2025, the Texas Attorney General separately sued Epic, alleging unlawful monopolization in electronic health records and deceptive practices tied to parental access settings in MyChart. Together, the cases increase the odds that Epic faces limits on how tightly it can control downstream access and defaults.

Going forward, the biggest consequence is that interoperability is shifting from a product feature to a regulated competitive boundary. If courts keep scrutinizing how Epic governs data access, more value can move to API and workflow companies that build on top of the EHR, while Epic will need to defend its moat with product quality and installed workflow depth rather than control over network participation alone.